The irony is that this Beaumont publication was distributed throughout the kiosks in the hospital on June 15, while Gil was being admitted downstairs through the ER with symptoms of what we now know to be AML.
The article describes the efforts of a statewide registry whose participating institutions were able to reduce radiation dosage in patients undergoing coronary CT based on methods developed by Gil and his team.
Their research had just been published in JAMA (Journal of the American Medical Association).
As Gil's star was rising professionally, his own health issues sidelined him from the celebration dinner with his fellow authors that would now have to be rescheduled.
On a medical note, Gil's condition should be improving in the next few days since they've started his TPN (much-needed calories).
He received his first of daily doses of Neupogen this morning. (Neupogen accelerates the recovery of the neutrophil count).
Go, neutrophils, go!